In this article, we will take a look at the 15 undervalued defensive stocks for 2023. You can skip this part and go to 5 Undervalued Defensive Stocks For 2023.
Investors flocked to defensive stocks in 2022 amid recession fears and massive losses in the growth stocks space. Defensive stocks are favored by investors during tough economic times as companies operating in the space feel little impact of the broader economic downturn. That’s because they sell products and services whose demand remains almost unchanged due to their essential nature. Defensive sectors include consumers staples, healthcare and utilities, among others. As of December 29, the S&P 500 utility stocks as a whole fell 0.5% in 2022, while consumer staples were down 2.7% in the period. Compare this performance to the broader market (SPY) decline of about 20% and you begin to understand why everyone wants to invest in undervalued defensive stocks when things go south.
Smart investors are continuing to prefer defensive stocks in 2023 as the economic outlook for this year paints no rosy picture. According a Wall Street Journal report, Lisa Erickson, head of the public markets group at U.S. Bank Wealth Management, believes the starting months of this year would continue to pose challenges. That’s why the investor reportedly said she is recommending dividend-paying defensive stocks to her clients.
“We’ve had a perfect setup for defensive companies… With that type of volatility expected again, companies that can provide more of a cash-flow buffer in their returns look attractive,” Erickson reportedly said.
Our Methodology
For this article, we used stock screeners to identify stocks with PE ratios less than 20 in the following three defensive sectors: consumer staples, healthcare and utilities. From the resultant dataset, we chose 15 stocks that had the most number of hedge funds invested in them. We also gave priority to dividend-paying companies since they are preferred by investors during recessions. The list is ranked in descending order of PE ratios.
Undervalued Defensive Stocks For 2023
15. Johnson & Johnson (NYSE:JNJ)
Forward PE Ratio as of January 27: 16.18
Johnson & Johnson (NYSE:JNJ) has a forward PE ratio of 16.18, according to Yahoo Finance. With 60 years of consecutive dividend increases and a stable and diversified business, Johnson & Johnson (NYSE:JNJ) is one of the best defensive stocks to buy for 2023.
Johnson & Johnson (NYSE:JNJ) recently posted strong Q4 results, which showed Johnson & Johnson (NYSE:JNJ)’s resiliency despite the macroeconomic headwinds. Johnson & Johnson (NYSE:JNJ) was able to pass on the impact of inflation to consumers. Johnson & Johnson (NYSE:JNJ)’s adjusted EPS in the fourth quarter came in at $2.35, which shows an over 10% increase on a YoY basis. The figure also beat analyst estimates by $0.11. For the full year, Johnson & Johnson (NYSE:JNJ) posted an EPS of $10.15, a 4% jump from the comparable period last year.
As of the end of the third quarter of 2022, 85 hedge funds had stakes in Johnson & Johnson (NYSE:JNJ). The total value of these stakes was $5.5 billion. The biggest stakeholder of Johnson & Johnson (NYSE:JNJ) was Ken Fisher’s Fisher Asset Management with a $967 million stake.
14. Philip Morris International Inc. (NYSE:PM)
PE Ratio as of January 27: 18.48
Philip Morris International Inc. (NYSE:PM), which has been raising its dividends for more than a decade now, is in the limelight after the stock was upgraded by Goldman Sachs to Buy from Neutral.
A total of 63 funds tracked by Insider Monkey had stakes in Philip Morris International Inc. (NYSE:PM) at the end of the third quarter of 2022, compared to 56 funds in the previous quarter.
Here is what Distillate Capital has to say about Philip Morris International Inc. (NYSE:PM) in its Q3 2022 investor letter:
“It makes intuitive sense that our process that employs bottom-up stock selection based on the combination of valuation and quality would reduce the weight in places that outperformed and add to areas that were weaker. The largest exited positions in the quarter were Philip Morris International Inc. (NYSE:PM), which saw its stability score fall slightly below the threshold for inclusion.”
13. Merck & Co., Inc. (NYSE:MRK)
PE Ratio as of January 27: 17.53
Another strong name from the pharma industry, Merck & Co., Inc. (NYSE:MRK) ranks 13th in our list of undervalued defensive stocks for 2023. Earlier in January, the FDA granted an additional indication for Merck & Co., Inc. (NYSE:MRK) Keytruda (pembrolizumab) as an adjuvant therapy for non-small cell lung cancer.
Merck & Co., Inc. (NYSE:MRK) stock has a dividend yield of over 2.7% as of January 29. Recently, Merck & Co., Inc. (NYSE:MRK) declared a quarterly dividend of $0.73 per share. The dividend is payable on April 10 for shareholders of record as of March 15.
Merck & Co., Inc. (NYSE:MRK) bulls believe the stock has long-term growth catalysts. Merck & Co., Inc. (NYSE:MRK) is expanding its presence in lucrative segments of the industry. For example, its acquisition of Imago has strengthened Merck & Co., Inc. (NYSE:MRK)’s position in the cancer therapeutics space.
Merck & Co., Inc. (NYSE:MRK) is also popular among hedge funds. As of the end of the third quarter, 82 hedge funds out of the 920 hedge funds tracked by Insider Monkey reported having stakes in Merck & Co., Inc. (NYSE:MRK). The total value of these stakes was $4.7 billion.
12. Altria Group, Inc. (NYSE:MO)
PE Ratio as of January 27: 17.15
Altria Group, Inc. (NYSE:MO) has increased its dividends for over 5 decades without any break. This makes Altria Group, Inc. (NYSE:MO) one of the best stocks to own amid recessions. However, Altria Group, Inc. (NYSE:MO) stock has been under pressure lately amid fears that the company’s cigarette sales are declining amid a broader downturn in the tobacco industry. However, Altria Group, Inc. (NYSE:MO) bulls believe the company is offsetting this decline by increasing per-pack prices. Some skeptics also question Altria Group, Inc. (NYSE:MO)’s dividend safety as Altria Group, Inc. (NYSE:MO)’s dividend yield stands at over 8%. However, the long-term outlook for Altria Group, Inc. (NYSE:MO) is strong and Altria Group, Inc. (NYSE:MO) is also enjoying a positive hedge fund sentiment. 47 hedge funds in the database of Insider Monkey had stakes in Altria Group, Inc. (NYSE:MO) as of the end of the third quarter.
The biggest stakeholder of Altria Group, Inc. (NYSE:MO) as of the end of the third quarter of 2022 was Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital which had a $383 million stake in Altria Group, Inc. (NYSE:MO). The second biggest stakeholder in Altria Group, Inc. (NYSE:MO) was John Overdeck and David Siegel’s Two Sigma Advisors, with a $290 million stake.
11. General Mills, Inc. (NYSE:GIS)
PE Ratio as of January 27: 16.27
Another food processing name from the consumer staples sector in our list, General Mills, Inc. (NYSE:GIS) stock was upgraded in January by UBS. General Mills, Inc. (NYSE:GIS) said the recent decline in General Mills, Inc. (NYSE:GIS) stock price was overblown.
“We think these fears are misplaced given the long runway for premiumization ahead driven by the humanization of pets trend and the NT visibility to margin recovery in the Pet segment,” UBS analysts said.
10. Kellogg Company (NYSE:K)
PE Ratio as of January 27: 15.57
Kellogg Company (NYSE:K) is one of the most favorite defensive plays of Wall Street. Kellogg Company (NYSE:K) in December approved a repurchase authorization of up to $1.5 billion, effective from January 1, 2023, until December 31, 2025.
A total of 25 hedge funds tracked by Insider Monkey are bullish on Kellogg Company (NYSE:K) as of the end of the third quarter.
9. Cardinal Health, Inc. (NYSE:CAH)
Forward PE Ratio as of January 27: 14.42
Cardinal Health, Inc. (NYSE:CAH) has increased its dividends consistently for the last 35 years. This pharma stock is also popular among hedge funds. Of the 920 funds tracked by Insider Monkey, 45 funds had stakes in Cardinal Health, Inc. (NYSE:CAH).
Ariel Investment made the following comment about Cardinal Health, Inc. (NYSE:CAH) in its Q3 2022 investor letter:
“Additionally, distributor of pharmaceutical and medical products Cardinal Health, Inc. (NYSE:CAH) advanced in the period as leadership changes were viewed to be a positive for shares. Management provided a new profit outlook for Fiscal 2023 and announced an improvement plan for the medical segment. We are encouraged by these changes and think CAH’s underlying fundamentals and competitive advantages around preventative maintenance screenings and medication management will continue to improve. We believe valuations of health care companies like CAH that focus on cost optimization and promote technological efficiency across the supply chain will be rewarded over the long term.”
8. The Kroger Co. (NYSE:KR)
PE Ratio as of January 27: 14.11
The Kroger Co. (NYSE:KR) is one of the obvious defensive stock picks for 2023 as The Kroger Co. (NYSE:KR) sells essential items at its stores whose demand remains more or less steady even during recessions. The Kroger Co. (NYSE:KR) also pays dividends and the stock’s PE ratio stands at 14.1 as of January 27.
Recently, Morgan Stanley upgraded The Kroger Co. (NYSE:KR) stock to Equal Weight from Under Weight.
7. British American Tobacco p.l.c. (NYSE:BTI)
PE Ratio as of January 27: 12.85
With a dividend yield of over 7% and a PE ratio of 12.8, British American Tobacco p.l.c. (NYSE:BTI) is one of the most undervalued defensive stocks to buy for 2023. British American Tobacco p.l.c. (NYSE:BTI) recently said it expects revenue growth of of 2% to 4% at a constant currency basis in fiscal 2022, amid an expansion of e-cigarette and oral nicotine products. British American Tobacco p.l.c. (NYSE:BTI) also said that it expects mid-single digit adjusted diluted earnings per share growth on a constant currency basis. British American Tobacco p.l.c. (NYSE:BTI) is still confident that it can deliver £5 billion in revenue, and profitability by 2025.
6. Archer-Daniels-Midland Company (NYSE:ADM)
PE Ratio as of January 27: 10.85
Another strong consumer defensive name in our list of undervalued defensive stocks to buy for 2023 is Archer-Daniels-Midland Company (NYSE:ADM). Archer-Daniels-Midland Company (NYSE:ADM) is currently in the limelight after it posted strong Q4 results and also increased its quarterly dividend. For the fourth quarter, Archer-Daniels-Midland Company (NYSE:ADM) said its revenue increased by a whopping 13.6% on a YoY basis to reach $26.2 billion. Archer-Daniels-Midland Company (NYSE:ADM) also pointed to strengths in ag services and oilseeds segments. This performance offset the declines in the carbohydrate solutions and nutrition segments. Operating profit in the quarter jumped 18% to $1.67 billion. Archer-Daniels-Midland Company (NYSE:ADM) also said that it will increase its focus on decarbonization of some of its large production facilities to enable the evolution of the carbohydrate solutions segment.
Archer-Daniels-Midland Company (NYSE:ADM) made investors happy by announcing a 12.5% increase in its quarterly dividend.
5. Bunge Limited (NYSE:BG)
PE Ratio as of January 27: 10.00
Missouri-based agribusiness and food company Bunge Limited (NYSE:BG) ranks 6th in our list of the undervalued defensive stocks for 2023. In November, Bunge Limited (NYSE:BG) announced a quarterly dividend of $0.625 per share. Forward dividend yield at the time came in at 2.35%.
4. Pfizer Inc. (NYSE:PFE)
PE Ratio as of January 27: 8.43
Pfizer Inc. (NYSE:PFE) is under pressure amid downgrades from Wall Street analysts who fear short-term challenges as we near the end of the COVID-19 pandemic. However, Pfizer Inc. (NYSE:PFE) remains one of the most stable and defensive companies. Pfizer Inc. (NYSE:PFE) has strong balance sheet and its pipeline is full of promising products. Pfizer Inc. (NYSE:PFE) has at least 19 near-term or expected product launches. These products can add approximately $20 billion in revenues in 2030. Some of Pfizer Inc. (NYSE:PFE)’s promising products are related to hematology, sickle cell disease, and obesity.
Pfizer Inc. (NYSE:PFE) is also a strong defensive player in recessions due to its dividend payments. Pfizer Inc. (NYSE:PFE) has upped its dividends consistently for over a decade now.
While we are nearing the end of the COVID-19 pandemic, there’s no surety that the world will be free of pandemics in the future. On that front, Pfizer Inc. (NYSE:PFE)’s is expanding its mRNA vaccine segment and expects to rake in $10 billion to $15 billion annually from this segment in the long term.
3. Post Holdings, Inc. (NYSE:POST)
PE Ratio as of January 27: 7.77
Post Holdings, Inc. (NYSE:POST) is a consumer packaged goods holding company. Analysts believe Post Holdings, Inc. (NYSE:POST)’s financial position will improve after the company sold BellRing Brands (BRBR).
In the fiscal fourth quarter results posted in November, Post Holdings, Inc. (NYSE:POST) said its adjusted EPS in the period came in at $0.85, beating estimates by $0.15. Revenue in the quarter fell 5.9% to $1.6 billion, beating estimates by a whopping $50 million. Post Holdings, Inc. (NYSE:POST) said that in fiscal 2023 it expects adjusted EBITDA to be between $990-$1,040 million.
As of the end of the third quarter, 29 hedge funds tracked by Insider Monkey had stakes in Post Holdings, Inc. (NYSE:POST). The total value of these stakes was over $1 billion. At the end of the second quarter, 26 hedge funds were bullish on Post Holdings, Inc. (NYSE:POST). The biggest stakeholder of Post Holdings, Inc. (NYSE:POST) at the end of the third quarter of 2022 was William Duhamel’s Route One Investment Company with a $573 million stake.
2. Tyson Foods, Inc. (NYSE:TSN)
PE Ratio as of January 27: 7.37
One of the major meat companies in the US, Tyson Foods, Inc. (NYSE:TSN) ranks 3rd in our list of undervalued defensive stocks for 2023. In the fourth quarter of 2022, Tyson Foods, Inc. (NYSE:TSN)’s adjusted EPS came in at $1.63 on $13.74 billion revenue, missing estimates of $1.72 EPS but beating forecasts of $13.49 billion for revenue. For 2023, Tyson Foods, Inc. (NYSE:TSN) said it expects profitability improvement as it prepares to cut costs.
As of the end of the third quarter, 35 hedge funds tracked by Insider Monkey had stakes in Tyson Foods, Inc. (NYSE:TSN).
1. GSK plc (NYSE:GSK)
PE Ratio as of January 27: 4.03
GSK plc (NYSE:GSK) is a British pharma giant. GSK plc (NYSE:GSK) has a PE ratio of 4.03 and a dividend yield of over 4% as of January 27. GSK plc (NYSE:GSK) has been around for about 200 years. It has one of the biggest R&D budgets in the industry. With a solid dividend and a diversified business model, GSK plc (NYSE:GSK) is strong enough to weather any economic storm. That’s why it made it to our list of the undervalued defensive stocks for 2023. In the third quarter, GSK plc (NYSE:GSK)’s revenue jumped about 9% on a YoY basis to reach £7.8 billion. GSK plc (NYSE:GSK) also upped its full-year guidance.
You can also take a peek at 15 Largest Plastic Manufacturing Companies in the World and 14 Countries Where Official Language is English.
Suggested articles:
- 15 Biggest Window Manufacturing Companies
- 12 Biggest Ocean Cleaning Companies in the World
- 13 Cash Rich Penny Stocks That Hedge Funds Are Buying
Disclosure: None. 15 Undervalued Defensive Stocks For 2023 is originally published on Insider Monkey.
